{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:25:04Z","timestamp":1763749504745,"version":"3.41.2"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":106,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To externally validate the PMR impact scale (PMR-IS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a prospective cohort study at the University Hospitals Leuven, Leuven, Belgium. Recently diagnosed PMR patients were included between July 2022 and December 2023 and followed until 1\u2009year after diagnosis. All patients completed the PMR-IS, HAQ Disability Index, 36-item Short Form and a visual analogue scale for pain at every visit. Internal consistency, floor and ceiling effects, construct validity, responsiveness and discriminatory power for detecting relapse on the PMR-IS were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-five PMR patients (mean age 71\u2009years, 47% female) were included, who had a total of 246 visits. Internal consistency, construct validity and responsiveness met the quality criteria for the symptoms, function and emotional and psychological well-being subdomains. The internal consistency of the glucocorticoid side effects subdomain was insufficient and only one of the three hypotheses for construct validity were met. The function and emotional and psychological well-being subdomains showed a floor effect, while no ceiling effect was observed. The symptoms, function and emotional and psychological well-being subdomains had a good discriminatory power for detecting relapse [area under the curve (AUC) 0.89, 0.86 and 0.72, respectively], but the PMR activity score performed better (AUC 0.94, P\u2009&amp;lt;\u20090.05 for all subdomains).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study validates the good measurement properties of the symptoms, function and emotional and psychological well-being subdomains of the PMR-IS. In contrast, the glucocorticoid side effects subdomain did not show adequate internal consistency and construct validity, necessitating further validation and possibly refinement of its items prior to application in clinical trials or daily practice.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rap\/rkaf046","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T16:31:16Z","timestamp":1744907476000},"source":"Crossref","is-referenced-by-count":1,"title":["External validation of the polymyalgia rheumatica impact scale: a prospective cohort study"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-4801","authenticated-orcid":false,"given":"Lien","family":"Moreel","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Microbiology, Immunology, and Transplantation, KU Leuven , Leuven,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u00ebl","family":"Doumen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Development and Regeneration, KU Leuven , Leuven,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-5001","authenticated-orcid":false,"given":"Albrecht","family":"Betrains","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Microbiology, Immunology, and Transplantation, KU Leuven , Leuven,","place":["Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-2146","authenticated-orcid":false,"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Development and Regeneration, KU Leuven , Leuven,","place":["Belgium"]},{"name":"European Reference Network for Immunodeficiency, Autoinflammatory, Autoimmune and Pediatric Rheumatic Disease (ERN-RITA) , Utrecht, The","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-1780","authenticated-orcid":false,"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Microbiology, Immunology, and Transplantation, KU Leuven , Leuven,","place":["Belgium"]},{"name":"European Reference Network for Immunodeficiency, Autoinflammatory, Autoimmune and Pediatric Rheumatic Disease (ERN-RITA) , Utrecht, The","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Vanderschueren","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, UZ Leuven , Leuven,","place":["Belgium"]},{"name":"Department of Microbiology, Immunology, and Transplantation, KU Leuven , Leuven,","place":["Belgium"]},{"name":"European Reference Network for Immunodeficiency, Autoinflammatory, Autoimmune and Pediatric Rheumatic Disease (ERN-RITA) , Utrecht, The","place":["Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2025052701323028200_rkaf046-B1","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2025052701323028200_rkaf046-B2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2015-207492","article-title":"2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative","volume":"74","author":"Dejaco","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025052701323028200_rkaf046-B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"author":"OMERACT (Outcome Measures in Rheumatology)","key":"2025052701323028200_rkaf046-B4"},{"key":"2025052701323028200_rkaf046-B5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3899\/jrheum.161109","article-title":"The OMERACT core domain set for outcome measures for clinical trials in polymyalgia rheumatica","volume":"44","author":"Mackie","year":"2017","journal-title":"J Rheumatol"},{"key":"2025052701323028200_rkaf046-B6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3899\/jrheum.200248","article-title":"Outcomes measured in polymyalgia rheumatica and measurement properties of instruments considered for the OMERACT core outcome set: a systematic review","volume":"48","author":"Twohig","year":"2021","journal-title":"J Rheumatol"},{"key":"2025052701323028200_rkaf046-B7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3899\/jrheum.181050","article-title":"Toward a core outcome measurement set for polymyalgia rheumatica: report from the OMERACT 2018 special interest group","volume":"46","author":"Owen","year":"2019","journal-title":"J Rheumatol"},{"key":"2025052701323028200_rkaf046-B8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/PROM.S156279","article-title":"The importance of patient-reported outcomes in clinical trials and strategies for future optimization","volume":"9","author":"Mercieca-Bebber","year":"2018","journal-title":"Patient Relat Outcome Meas"},{"key":"2025052701323028200_rkaf046-B9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmjqs-2013-002524","article-title":"The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research","volume":"23","author":"Boyce","year":"2014","journal-title":"BMJ Qual Saf"},{"key":"2025052701323028200_rkaf046-B10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pec.2014.12.013","article-title":"\u201cI suddenly felt I\u2019d aged\u201d: a qualitative study of patient experiences of polymyalgia rheumatica (PMR)","volume":"98","author":"Twohig","year":"2015","journal-title":"Patient Educ Couns"},{"key":"2025052701323028200_rkaf046-B11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40814-017-0150-y","article-title":"Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire","volume":"4","author":"Twohig","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"2025052701323028200_rkaf046-B12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/rheumatology\/keac317","article-title":"Development and psychometric evaluation of the PMR-Impact Scale: a new patient reported outcome measure for polymyalgia rheumatica","volume":"62","author":"Twohig","year":"2023","journal-title":"Rheumatology (Oxford)"},{"volume-title":"COSMIN methodology for conducting systematic reviews of patient-reported outcome measures (PROMs)","year":"2018","author":"Mokkink","key":"2025052701323028200_rkaf046-B13"},{"key":"2025052701323028200_rkaf046-B14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J Clin Epidemiol"},{"volume-title":"Statistical power analysis for the behavioral sciences","year":"1988","author":"Cohen","key":"2025052701323028200_rkaf046-B15"},{"key":"2025052701323028200_rkaf046-B16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Care Res"},{"key":"2025052701323028200_rkaf046-B17","doi-asserted-by":"crossref","first-page":"105680","DOI":"10.1016\/j.jbspin.2023.105680","article-title":"Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: a cohort study using routinely collected health data","volume":"91","author":"Tanaka","year":"2024","journal-title":"Jt Bone Spine"},{"key":"2025052701323028200_rkaf046-B18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3899\/jrheum.110851","article-title":"Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study","volume":"39","author":"Mazzantini","year":"2012","journal-title":"J Rheumatol"},{"volume-title":"COSMIN methodology for assessing the content validity of PROMs","year":"2018","author":"Terwee","key":"2025052701323028200_rkaf046-B19"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkaf046\/62949903\/rkaf046.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf046\/62949903\/rkaf046.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/9\/2\/rkaf046\/62949903\/rkaf046.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T05:32:43Z","timestamp":1748323963000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf046\/8115595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf046","relation":{},"ISSN":["2514-1775"],"issn-type":[{"type":"electronic","value":"2514-1775"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rkaf046"}}